FDA to pilot faster review of generic drugs manufactured in the US
Sets bioequivalence and active pharmaceutical ingredient (API) requirements for its new ANDA prioritisation programme.
List view / Grid view
Sets bioequivalence and active pharmaceutical ingredient (API) requirements for its new ANDA prioritisation programme.
The investment will cover CMO collaborations and a new manufacturing and quality hub in Hyderabad.
7 October 2025 | By Rapid Micro Biosystems
This webinar showcases a rapid microbial method that can help to address the time to result challenge posed by short shelf-life radiopharmaceuticals.
This update includes sterile manufacturing, bio-manufacturing, cell line development and radiopharmaceuticals.
Pharma manufacturing facility construction placed at the heart of a policy announcement made on social media.
This whitepaper provides a detailed examination of Lonza’s holistic, data-driven approach to CCI, developed in collaboration with industry experts and applied across our global network for parenteral combination products.
The new $6.5 billion Houston site will manufacture active pharmaceutical ingredients (APIs) in support of the company’s pipeline of small molecule medicines.
EPR Issue 3 includes articles on microbiology, downstream processing, manufacturing, drug formulation and more.
Winners of this year's awards will be revealed during the opening of CPHI Frankfurt 2025.
The new $5 billion manufacturing site is set to become the company’s first integrated facility for API and drug product manufacturing.
The company’s investment strategy will also encompass AI, digital technology and supply chain infrastructure.
The novel approach could enhance quality testing applications in pharmaceutical manufacturing.
European Parliament's SANT Committee urges for greater control on medicine provisions to help strengthen security of supply.
2 September 2025 | By FUJIFILM Wako Europe GmbH
Join this webinar to find out how RT-rt PCR is revolutionising sterility testing and discover a unique approach that provides reliable one-day results and enhanced sensitivity and detection capabilities.
Contracts to use a facility at Fujifilm’s North Carolina site as part of moves to onshore its manufacturing.